A grey day in Hamburg spent discussing all things virology and CRISPR screening at the DEFENDER symposium - an EU funded consortium on a mission to identify new targets and develop new therapies against high priority viruses.
A readily implementable strategy to improve AAV capsid filling. No need to even change your plasmids, just delay Rep/Cap transfection!
Great work from the Nesbeth lab and first author Qiangtong (Tina) Chen!
@GenePlumber @UCLBiochemEng1 @ucl
Delighted to have successfully defended my PhD last month!
We built DNA clearing HEK cells and designed AAV protein variants to study their function and improve AAV manufacturing!
Huge thanks to my PI @GenePlumber, everyone @UCLBiochemEng1, examiners @alanlparker & @pauldalby!
We also showed that AAV9 produced from these "NuPro-1S" cells remains comparably active in-vivo. Many thanks to @DrGiuliaMassaro and @ProfAhadRahim from @School_Pharmacy for assisting with this!
2
77
Delighted to share the latest publication from the Nesbeth lab, my second first-author manuscript. We engineered suspension HEK cells to express a secretory nuclease which reduced DNA impurities and (serendipituously) increased AAV yields!
doi.org/10.1016/j.omtm.2024.…
@GenePlumber
Great listening to @CaGuAcRo1 speaking about directed evolution and a synthetic biology, AI driven pipeline for protein engineering. An exciting space to watch for sure @DTUBiosustain! Thanks @DrLeoRios for organising!
#DesignTestBuildLearn #synbio #proteineng
It was great attending the Advancing Manufacture of Cell and Gene Therapies VIII conference in San Diego last week. Listened to some great talks and had some inspiring conversations!
Also presented a poster on engineered HEK cells to reduce DNA impurities in vector production!
A fitting book for the flight to San Diego for the ECI cell and gene therapy conference! From 1850’s Mendel to the Asilomar II meeting in 1975 to guide gene cloning, especially the ban on cloning human DNA into viruses, to today - mass producing viral vectors to cure disease!
5
143














